DMD and Duchenne muscular dystrophy: These findings are similar to those reported by Scaglioni et al., who investigated dystrophin and β-dystroglycan expression in muscle biopsy samples from DMD patients treated with golodirsen (an exon-skipping drug designed to skip DMD exon 53).54